top of page
SmallDepositphotos_75623507_XL.jpg

ABOUT SYNTHERIX

SYNTHERIX is a Biotechnology company set up to develop and commercilalise ONKONEK, a drug that kills cancer cells in a totally new and different way by causing them to run out of energy.

A New Drug That Kills Cancer In A Totally Different Way

A Key Breakthrough
In Understanding Cancer

CURRENT THERAPIES ARE NOT THE COMPLETE ANSWER

CHEMOTHERAPY tries to kill cancer cells by preventing them dividing

Chemotherapy has well known side effects damaging normal tissues such as hair, blood, bowel etc

Arrow.png

Even drugs attacking specific oncogenes are not without side effects

Arrow.png

Both treatments are able to slow the growth rate of cancer but rarely cure it

MODERN IMMUNOTHERAPY

Despite initial successes against melanoma, immunotherapy is now starting to show discouraging results in other cancers and large Biopharma have culled over 40 immuno-oncology projects in the last 6 months.

THE BENEFITS

THE BENEFITS OF ONKONEK

Icons-01.png

Avoids Side Effects

Should avoid the side-effects of chemotherapy and immunotherapy

Icons-03.png

Works Differently

Reduces the energy of the cell and as a consequence drowns it

Icons-02.png

Globally Effective

Broad Global effect against most types of cancer

Screenshot 2023-02-24 at 18.37.19.png

ABOUT ONKONEK

SYNTHERIX’s lead agent ONKONEK works in a novel way which should avoid the side-effects of chemotherapy and immunotherapy because it does not affect normal cells.

 

ONKONEK also has a broad global effect against most different types of cancer.

 

ONKONEK is based on an entirely new concept supported by over a decade of laboratory studies.

 

The way it works makes sense.

bottom of page